Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Jun 25;51(3):341-349. doi: 10.3724/zdxbyxb-2022-0121.
To evaluate the clinical effect and safety of one-stop endovascular intervention in treatment of left iliac vein compression syndrome (IVCS) complicated with deep venous thrombosis (DVT) of lower limbs.
Clinical data of 26 patients with secondary DVT due to IVCS admitted in the Department of Vascular Surgery, Hebei General Hospital from January 2018 to December 2021 were retrospectively analyzed. All patients underwent one-stop endovascular intervention procedure, including ultrasound-guided deep venipuncture, Angiojet catheter aspiration, iliac vein balloon dilation, stent implantation and simultaneous filter retrieval. The operation time and catheter aspiration time were documented; the preoperative and postoperative left lower extremity deep vein venous patency, circumferences of bilateral limbs at 15 cm above the knee and 10 cm below the knee, and the levels of hemoglobin, creatinine, alanine aminotransferase (ALT), aspertate aminotransferase (AST), total bilirubin and indirect bilirubin were measured. The incidence of post-thrombotic syndrome (PTS) and iliac vein stent patency were recorded through follow-up.
The one-stop endovascular intervention was successfully performed in 26 patients, with the operation time of (171±35) min and the thrombolysis time of (263±89) s. After treatment, the left lower extremity deep vein venous patency, circumferences of bilateral limbs at 15 cm above the knee and 10 cm below the knee were decreased (all <0.01); the hemoglobin level were decreased, the creatinine, ALT, AST, total bilirubin and indirect bilirubin levels were increased (all <0.01). Patients were followed up for 1-12 months. Stent thrombosis occurred in 1 patient 7 months after procedure, and the symptoms were improved after conservative treatment; the stents were unobstructed in all patients, 1 patient had stent mural thrombosis, in whom the stent blood flow was not affected. No PTS was observed during the follow-up.
The one-stop endovascular interventional treatment of IVCS complicated with DVT of left lower limb is safe and effective. Attention should be paid to the changes of liver and kidney function caused by catheter aspiration during the treatment, and corresponding intervention should be given in time to avoid the occurrence of related complications.
评估一站式血管腔内介入治疗左髂静脉压迫综合征(IVCS)合并下肢深静脉血栓形成(DVT)的临床效果和安全性。
回顾性分析 2018 年 1 月至 2021 年 12 月河北医科大学第一医院血管外科收治的 26 例因 IVCS 导致继发性 DVT 的患者临床资料。所有患者均采用超声引导下深静脉穿刺、Angiojet 导管抽吸、髂静脉球囊扩张、支架植入及同期滤器取出一站式血管腔内介入治疗,记录手术时间、导管抽吸时间;测量术前及术后左下肢深静脉通畅情况、双侧膝关节上 15cm、膝关节下 10cm 周径;检测血红蛋白、肌酐、丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、总胆红素、间接胆红素水平。通过随访记录患者血栓后综合征(PTS)及髂静脉支架通畅情况。
26 例患者一站式血管腔内介入治疗均顺利完成,手术时间为(171±35)min,溶栓时间为(263±89)s。治疗后,患者左下肢深静脉通畅情况、双侧膝关节上 15cm、膝关节下 10cm 周径均减小(均<0.01);血红蛋白水平降低,肌酐、ALT、AST、总胆红素、间接胆红素水平均升高(均<0.01)。患者均获得随访,随访时间 1~12 个月。术后 7 个月 1 例患者出现支架内血栓形成,经保守治疗后症状改善;所有患者支架通畅,1 例患者支架壁内血栓形成,但支架血流不受影响。随访期间无 PTS 发生。
一站式血管腔内介入治疗左下肢 IVCS 合并 DVT 安全、有效。治疗过程中应注意导管抽吸引起的肝肾功能变化,及时给予相应干预,避免相关并发症发生。